Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study

  • Sander W. van der Laan*
  • , Tove Fall
  • , Aicha Soumaré
  • , Alexander Teumer
  • , Sanaz Sedaghat
  • , Jens Baumert
  • , Delilah Zabaneh
  • , Jessica van Setten
  • , Ivana Isgum
  • , Tessel E. Galesloot
  • , Johannes Arpegård
  • , Philippe Amouyel
  • , Stella Trompet
  • , Melanie Waldenberger
  • , Marcus Dörr
  • , Patrik K. Magnusson
  • , Vilmantas Giedraitis
  • , Anders Larsson
  • , Andrew P. Morris
  • , Janine F. Felix
  • Alanna C. Morrison, Nora Franceschini, Joshua C. Bis, Maryam Kavousi, Christopher O'Donnell, Fotios Drenos, Vinicius Tragante, Patricia B. Munroe, Rainer Malik, Martin Dichgans, Bradford B. Worrall, Jeanette Erdmann, Christopher P. Nelson, Nilesh J. Samani, Heribert Schunkert, Jonathan Marchini, Riyaz S. Patel, Aroon D. Hingorani, Lars Lind, Nancy L. Pedersen, Jacqueline de Graaf, Lambertus A.L.M. Kiemeney, Sebastian E. Baumeister, Oscar H. Franco, Albert Hofman, André G. Uitterlinden, Wolfgang Koenig, Christa Meisinger, Annette Peters, Barbara Thorand, J. Wouter Jukema, Bjørn Odvar Eriksen, Ingrid Toft, Tom Wilsgaard, N. Charlotte Onland-Moret, Yvonne T. van der Schouw, Stéphanie Debette, Meena Kumari, Per Svensson, Pim van der Harst, Mika Kivimaki, Brendan J. Keating, Naveed Sattar, Abbas Dehghan, Alex P. Reiner, Erik Ingelsson, Hester M. den Ruijter, Paul I.W. de Bakker, Gerard Pasterkamp, Johan Ärnlöv, Michael V. Holmes, Folkert W. Asselbergs
*Korrespondierende/r Autor/-in für diese Arbeit
  • Laboratory of Experimental Cardiology
  • Utrecht University
  • Uppsala University
  • University of Bordeaux
  • Universität Greifswald
  • Charite - Universitatsmedizin Berlin
  • Erasmus Medical College
  • Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
  • University College London
  • Genetics Institute
  • Radboud-Universität Nijmegen
  • Department of Emergency Medicine
  • Karolinska Institutet
  • Cardiovascular Genetics and Genomics Group
  • Université Lille-Nord de France
  • Institut Pasteur de Lille
  • Leiden University
  • Department of Medical Epidemiology and Biostatistics
  • University of Liverpool
  • Wellcome Trust Centre for Human Genetics
  • Baylor College of Medicine
  • University of North Carolina
  • University of Washington, Seattle
  • Boston Veterans Administration Healthcare
  • NHLBI's Framingham Heart Study
  • MRC Integrative Epidemiology Unit
  • University of Bristol
  • Queen Mary University of London
  • Institute for Stroke and Dementia Research
  • Ludwig-Maximilians-Universität
  • Munich Cluster for Systems Neurology (SyNergy)
  • University of Virginia
  • University of Leicester
  • Leicester National Institute for Health Research Biomedical Research Unit in Cardiovascular Disease
  • Glenfield Hospital
  • Department of Statistics
  • Oxford University Hospitals NHS Foundation Trust
  • The Genetic Epidemiology Research Group
  • Bart's Heart Centre
  • Farr Institute of Health Informatics
  • Universität Regensburg
  • Technische Universität München
  • Universität Ulm
  • Durrer Center for Cardiogenetic Research
  • Interuniversity Cardiology Institute of the Netherlands
  • Metabolic and Renal Research Group
  • UiT The Arctic University of Norway
  • Section of Nephrology
  • University Hospital of North Norway
  • Department of Community Medicine
  • Biological and Social Epidemiology
  • University of Essex
  • Universiteit Groningen
  • Department of Twin Research and Genetic Epidemiology
  • Department of Surgery
  • University of Pennsylvania
  • University of Glasgow
  • Stanford University
  • CTSU
  • Institute of Cardiovascular Science

Abstract

Background Epidemiological studies show that high circulating cystatin C is associated with risk of cardiovascular disease (CVD), independent of creatinine-based renal function measurements. It is unclear whether this relationship is causal, arises from residual confounding, and/or is a consequence of reverse causation. Objectives The aim of this study was to use Mendelian randomization to investigate whether cystatin C is causally related to CVD in the general population. Methods We incorporated participant data from 16 prospective cohorts (n = 76,481) with 37,126 measures of cystatin C and added genetic data from 43 studies (n = 252,216) with 63,292 CVD events. We used the common variant rs911119 in CST3 as an instrumental variable to investigate the causal role of cystatin C in CVD, including coronary heart disease, ischemic stroke, and heart failure. Results Cystatin C concentrations were associated with CVD risk after adjusting for age, sex, and traditional risk factors (relative risk: 1.82 per doubling of cystatin C; 95% confidence interval [CI]: 1.56 to 2.13; p = 2.12 × 10−14). The minor allele of rs911119 was associated with decreased serum cystatin C (6.13% per allele; 95% CI: 5.75 to 6.50; p = 5.95 × 10−211), explaining 2.8% of the observed variation in cystatin C. Mendelian randomization analysis did not provide evidence for a causal role of cystatin C, with a causal relative risk for CVD of 1.00 per doubling cystatin C (95% CI: 0.82 to 1.22; p = 0.994), which was statistically different from the observational estimate (p = 1.6 × 10−5). A causal effect of cystatin C was not detected for any individual component of CVD. Conclusions Mendelian randomization analyses did not support a causal role of cystatin C in the etiology of CVD. As such, therapeutics targeted at lowering circulating cystatin C are unlikely to be effective in preventing CVD.
OriginalspracheEnglisch
ZeitschriftJournal of the American College of Cardiology
Jahrgang68
Ausgabenummer9
Seiten (von - bis)934-945
Seitenumfang12
ISSN0735-1097
DOIs
PublikationsstatusVeröffentlicht - 30.08.2016

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen
  2. SDG 5 – Gender Equality
    SDG 5 – Gender Equality

Fingerprint

Untersuchen Sie die Forschungsthemen von „Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren